Abstract 470: High-dose TSLP decreases in vivo tumor burden in preclinical models of CRLF2 B-ALL
Year: 2020
Type: conference-abstract
Source: Cancer Research
Institutions: Loma Linda University, Pennsylvania State University
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3083604751
